title: Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.
abstract: Peritoneal dialysis (PD) is an effective home-based therapy for end-stage renal failure. Intraperitoneal administration of drugs to PD patients is particularly important for the treatment of peritonitis. Clinicians need to know that the administered drug is compatible with both the PD solution and its container. A detailed literature search on drug compatibility and stability was performed and results of all published stability studies are presented for all drugs, PD solutions, and containers studied. These data will aid clinicians managing PD patients and provide a resource to demonstrate which drugs have been shown to be stable in various PD solutions and solution containers. This is important information to assist clinicians in applying effective treatments, in particular, for peritonitis.
authors.affiliation: Baxter R&D Europe, Nivelles, Belgium.
authors.forename: Filip
authors.initials: F
authors.lastname: de Vin
authors.forename: Peter
authors.initials: P
authors.lastname: Rutherford
authors.forename: Dirk
authors.initials: D
authors.lastname: Faict
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage*; D006801:Humans; D007274:Injections, Intraperitoneal; D007676:Kidney Failure, Chronic / Q000628:therapy; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents